why choose us

First received: June 10, 2024

Clinical Trial: Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Peripheral Neuropathy Due to Chemotherapy

Study Type: INTERVENTIONAL


Official Title: Evaluation of Trimetazidine in Alleviating Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients

Brief Summary: This proof-of-concept study evaluated the effect of Trimetazidine on the incidence of paclitaxel-induced peripheral neuropathy in patients with breast cancer.

Read more